A drug called OBI-3424 has been designated an Orphan Drug by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukaemia, based predominantly on research carried out by our Leukaemia Biology Program.
Olivia Lambert was a bright and happy little girl with an infectious smile and a fun-loving spirit. Diagnosed with stage 4 neuroblastoma at age two and a half, she fought the disease bravely for six years. Her legacy and spirit continue with the appointment of Dr Joshua McCarroll as the Olivia Lambert Team Leader.
This week we’re looking at Drug Discovery – the development of new cancer treatments. Because it’s only with more effective, less toxic cancer drugs that we’ll be able to save the life of every child with cancer and improve their long-term health.
The 9th International Nanomedicine Conference was held last week in Coogee, Sydney. Some of our researchers were there, showcasing their research and networking with colleagues from near and far.
Our scientists have been forging alliances in China that will open the door to research collaborations and speed the progress of childhood cancer research.
Last week a group of our scientists were in San Francisco attending The Advances in Neuroblastoma Research (ANR) conference. One of them, Dr Jayne Murray, tells us about it.
In the approach to Mother’s Day, one of our incredible supporters, Sasha, contacted us about some words she had written as she was thinking about the approach of her first Mother’s Day without her son Byron. Byron sadly passed away from Neuroblastoma on the 12th August 2017, just 9 days before his 3rd birthday.
NSW Health Minister Brad Hazzard has announced a $1 million funding boost for the Zero Childhood Cancer program. The money will support an immunotherapy trial for children with brain cancer.
One of our Clinical Research Fellows, Dr Toby Trahair, is taking part in the Tour de Cure Signature Tour 2018 which starts on Friday 27th April, raising money for cancer research by cycling 1110km from Mackay to Cairns.
Mackenzie was diagnosed with Acute Lymphoblastic Leukaemia (ALL) at just 9 years old. Her mum, Errin, has recently spoken about Mackenzie’s journey.